Geneva Capital Management’s Cerence CRNC Stock Holding History
Bought
Maintained
Sold
Other funds holding CRNC
CCPM
VBA
VVP
Geneva Capital Management's CRNC Position: Q4 2022 in Review
Geneva Capital Management sold out of Cerence (CRNC) in Q4 2022, closing a stake of 197,307 shares — an estimated $3.11M sold.
Geneva Capital Management first reported a position in CRNC in Q3 2020 and held it in 9 quarters. The position peaked at $55.5M in Q3 2021. 223 funds tracked by Wall St. Rank hold CRNC as of Q4 2022.
- Geneva Capital Management reported no remaining Cerence position as of Q4 2022 after selling out during the quarter.
- Geneva Capital Management sold 197,307 Cerence shares in Q4 2022, an estimated $3.11M.
- Geneva Capital Management first reported a position in Cerence in Q3 2020 and held it in 9 quarters.
- Geneva Capital Management's Cerence position peaked at $55.5M in Q3 2021.
- 223 funds tracked by Wall St. Rank held Cerence as of Q4 2022.
Based on Geneva Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.